PharmacoEconomics & Outcomes News

, Volume 413, Issue 1, pp 5–5 | Cite as

ACE inhibitors not worth it as first-line therapy in hypertension

Clinical study


Left Ventricular Hypertrophy Conventional Therapy Antihypertensive Therapy Acquisition Cost Relative Risk Reduction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2003

Personalised recommendations